| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.031 | 4.508 | 9.006 | 3.458 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 2.031 | 4.508 | 9.006 | 3.458 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 611 | 4.358 | 3.226 | 3.651 | 2.570 | 1.097 | 1.508 | 1.824 |
| Gross Profit/Loss - EUR | - | - | 1.421 | 151 | 5.779 | -192 | -2.570 | -1.097 | -1.508 | -1.824 |
| Net Profit/Loss - EUR | - | - | 1.360 | 15 | 5.563 | -286 | -2.570 | -1.097 | -1.508 | -1.824 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ms & Mt Medidesign Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 66 | 0 | 478 | 635 | 158 | 119 | 1.436 | 786 |
| Current Assets | - | - | 2.594 | 4.050 | 10.799 | 6.620 | 5.227 | 4.683 | 2.217 | 1.654 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 19 | 19 | 19 | 18 |
| Receivables | - | - | 2.417 | 0 | 91 | 227 | 236 | 240 | 581 | 578 |
| Cash | - | - | 176 | 4.050 | 10.708 | 6.394 | 4.972 | 4.425 | 1.618 | 1.058 |
| Shareholders Funds | - | - | 1.404 | 1.393 | 6.929 | 6.512 | 3.797 | 2.712 | 1.196 | -635 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.257 | 2.657 | 4.348 | 743 | 1.587 | 2.090 | 2.457 | 3.075 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Ms & Mt Medidesign Consulting Srl